Difficulty: Medium
Average Score: 91%
Practice
Aminocapronic acid is a drug of choice for treatment of:
Correct answer
B
Rationale
The correct answer is B: Bleeding from fibrinolytic therapy. Aminocaproic acid is an antifibrinolytic agent that works by inhibiting the breakdown of blood clots. It is commonly used to manage excessive bleeding caused by fibrinolytic therapy, such as in cases of severe bleeding post-surgery or trauma. This drug helps to maintain clot stability and prevent further bleeding.
Incorrect choices:
A: Acute myocardial infarction - Aminocaproic acid is not indicated for the treatment of acute myocardial infarction.
C: Heart failure - Aminocaproic acid is not used in the treatment of heart failure.
D: Multiple pulmonary emboli - Aminocaproic acid is not typically used to treat multiple pulmonary emboli.
Incorrect choices:
A: Acute myocardial infarction - Aminocaproic acid is not indicated for the treatment of acute myocardial infarction.
C: Heart failure - Aminocaproic acid is not used in the treatment of heart failure.
D: Multiple pulmonary emboli - Aminocaproic acid is not typically used to treat multiple pulmonary emboli.